Health Tip of the Week, sponsored by Baton Rouge General: Ozempic and Mounjaro … why is everyone talking about them?

The drastic increase in the popularity of both Ozempic and Mounjaro has caused a nationwide shortage of what some call a “miracle drug.” But some experts believe that the people driving the shortage of the drugs have neither diabetes nor obesity and are using the drug for one of its main side effects: weight loss. The shortage is particularly troublesome for those with type 2 diabetes who are struggling to get the medication needed to manage their blood sugar. It is important to note that neither Ozempic or Mounjaro are FDA approved as weight-loss drugs and much more research is needed to determine the long-term effects on those with no diabetes or obesity diagnosis. Learn more about Ozempic and Mounjaro.